Discontinuation report IMIPENEM AND CILASTATIN FOR INJECTION USP

Last updated on 2021-08-23 History
Report ID 144467
Drug Identification Number 02358336
Brand name IMIPENEM AND CILASTATIN FOR INJECTION USP
Common or Proper name IMIPENEM AND CILASTATIN FOR INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CILASTATIN IMIPENEM
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10PSOIJ CA
ATC code J01DH
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-08-20
Remaining supply date 2021-08-20
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-08-23 French Compare
v1 2021-08-23 English Compare